Sign up to access historical data
Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
PfizerPFE |
-$140,000 |
 |
Johnson & JohnsonJNJ |
-$104M |
 |
Mind Medicine (MindMed)MNMD |
-$45M |
 |
ModernaMRNA |
-$329B |
 |
AbbVieABBV |
-$945M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| HEATON LARRY C II | Sep 5, 2024 | Buy | 100,000 | $0.125 | $13,000 |
| POWERS JOHNNY D | Aug 28, 2024 | Buy | 100,000 | $0.129 | $13,000 |
| Blair Anthony K | Aug 20, 2024 | Buy | 100,000 | $0.142 | $14,000 |
| Klass Russell Kevin | Jun 12, 2024 | Buy | 299,993 | $0.1551 | $47,000 |
| Klass Russell Kevin | Jun 11, 2024 | Buy | 500,000 | $0.1502 | $75,000 |
| Klass Russell Kevin | Jun 10, 2024 | Buy | 200,007 | $0.1497 | $30,000 |
| Donato Peter | Jun 10, 2024 | Buy | 25,000 | $0.1519 | $3,800 |
| POWERS JOHNNY D | May 17, 2024 | Buy | 50,000 | $0.17 | $8,500 |
| POWERS JOHNNY D | May 16, 2024 | Buy | 25,000 | $0.184 | $4,600 |
| POWERS JOHNNY D | May 14, 2024 | Buy | 30,594 | $0.14 | $4,300 |
| POWERS JOHNNY D | May 14, 2024 | Buy | 19,406 | $0.139 | $2,700 |
| POWERS JOHNNY D | May 13, 2024 | Buy | 100,000 | $0.14 | $14,000 |
| Blair Anthony K | May 13, 2024 | Buy | 150,000 | $0.14 | $21,000 |
| HEATON LARRY C II | May 13, 2024 | Buy | 100,000 | $0.142 | $14,000 |
| POWERS JOHNNY D | Dec 15, 2023 | Buy | 100,000 | $0.165 | $17,000 |
| POWERS JOHNNY D | Dec 15, 2023 | Buy | 100,000 | $0.165 | $17,000 |
| POWERS JOHNNY D | Nov 17, 2023 | Buy | 100,000 | $0.166 | $17,000 |
| HEATON LARRY C II | Nov 17, 2023 | Buy | 100,000 | $0.166 | $17,000 |
| POWERS JOHNNY D | Nov 15, 2023 | Buy | 150,000 | $0.173 | $26,000 |
| HEATON LARRY C II | May 26, 2023 | Buy | 100,000 | $0.1909 | $19,000 |
| POWERS JOHNNY D | May 25, 2023 | Buy | 100,000 | $0.1934 | $19,000 |
What's the latest insider transaction for Zomedica?
The most recent insider transaction for Zomedica was conducted by HEATON LARRY C II, who sold 100,000 shares on September 5, 2024 at a price of $0.13 per share.
Which insider bought the most ZOM stock over the last two years?
Klass Russell Kevin has bought the most ZOM stock in the last 2 years, with a total value of $150,000.
What is the total value of insider transactions for Zomedica (ZOM) in the last 2 years?
According to our estimates, the total value of insider transactions for Zomedica in the last 2 years is positive, amounting to $390,000. This indicates that insiders have predominantly bought shares, showcasing their confidence in the company's future prospects.
How do insider transactions over the last 2 years reflect on Zomedica's market confidence?
Over the last 2 years, insider transactions for Zomedica have predominantly involved purchasing shares, indicating a strong confidence among insiders in the company's future prospects. This trend of more purchases than sales could be a positive signal to potential investors about the insiders' view on the company's valuation and growth potential.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
